Atlas Capital Advisors’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-5,471
Closed -$1.5M – 967
2021
Q2
$1.5M Hold
5,471
– – 0.25% 86
2021
Q1
$1.43M Hold
5,471
– – 0.28% 82
2020
Q4
$1.4M Hold
5,471
– – 0.29% 75
2020
Q3
$1.29M Hold
5,471
– – 0.31% 76
2020
Q2
$1.06M Hold
5,471
– – 0.25% 90
2020
Q1
$906K Hold
5,471
– – 0.27% 87
2019
Q4
$937K Hold
5,471
– – 0.23% 110
2019
Q3
$902K Hold
5,471
– – 0.27% 106
2019
Q2
$653K Hold
5,471
– – 0.21% 132
2019
Q1
$520K Hold
5,471
– – 0.19% 144
2018
Q4
$434K Hold
5,471
– – 0.17% 155
2018
Q3
$548K Hold
5,471
– – 0.18% 150
2018
Q2
$478K Hold
5,471
– – 0.17% 161
2018
Q1
$474K Buy
+5,471
New +$425K 0.15% 190

Other funds holding PODD

Atlas Capital Advisors's PODD Position: Q3 2021 in Review

Atlas Capital Advisors sold out of Insulet (PODD) in Q3 2021, closing a stake of 5,471 shares — an estimated $1.5M sold.

Atlas Capital Advisors first reported a position in PODD in Q1 2018 and held it in 14 quarters. The position peaked at $1.5M in Q2 2021. 433 funds tracked by Wall St. Rank hold PODD as of Q3 2021.

  • Atlas Capital Advisors reported no remaining Insulet position as of Q3 2021 after selling out during the quarter.
  • Atlas Capital Advisors sold 5,471 Insulet shares in Q3 2021, an estimated $1.5M.
  • Atlas Capital Advisors first reported a position in Insulet in Q1 2018 and held it in 14 quarters.
  • Atlas Capital Advisors's Insulet position peaked at $1.5M in Q2 2021.
  • 433 funds tracked by Wall St. Rank held Insulet as of Q3 2021.

Based on Atlas Capital Advisors's 13F filing for Q3 2021, filed 28 Oct 2021.